IE40788L - Dithiolanes and dithianes. - Google Patents

Dithiolanes and dithianes.

Info

Publication number
IE40788L
IE40788L IE742531A IE253174A IE40788L IE 40788 L IE40788 L IE 40788L IE 742531 A IE742531 A IE 742531A IE 253174 A IE253174 A IE 253174A IE 40788 L IE40788 L IE 40788L
Authority
IE
Ireland
Prior art keywords
alkyl
chain
carbon atoms
image
hydroxyl
Prior art date
Application number
IE742531A
Other versions
IE40788B1 (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Priority to IE2292/77A priority Critical patent/IE40790B1/en
Priority to IE229174A priority patent/IE40789B1/en
Publication of IE40788L publication Critical patent/IE40788L/en
Publication of IE40788B1 publication Critical patent/IE40788B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/06Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Novel sulphur-containing compounds which have coronary-dilating properties, of the formula <IMAGE> in which R represents a radical of the formula <IMAGE> or <IMAGE> R1, R2 and R3 represent hydrogen, halogen, lower alkyl, lower alkoxy, aryl-lower-alkoxy, aryloxy, phenyl, nitro, amino, lower alkylthio, trifluoromethyl, hydroxyl, cyano, di-lower alkylamino, lower alkanoylamino, carboxyl, lower alkoxycarbonyl, lower alkylsulphonyl, hydroxymethyl, lower alkanoyloxy, amido, lower alkanoyl, sulphamoyl, mono- or di-lower-alkyl-sulphamoyl, aminocarbonyloxy, mono- or di-lower-alkyl-aminocarbonyloxy, lower-alkyl-amino-lower-alkyl, or two adjacent radicals together represent methylenedioxy, ethylenedioxy or butadien-1,3-yl-1,4-ene, R4 represents hydrogen or lower alkyl, R5, R6 and R7 represent hydrogen, halogen, lower alkyl, lower alkoxy, hydroxyl or benzyloxy, or two adjacent radicals together represent methylenedioxy or ethylenedioxy, X represents a sulphur atom, SO or SO2, Y represents a straight-chain or branched, optionally hydroxyl-substituted aliphatic radical having 2-8 carbon atoms of which 2-4 carbon atoms are located in the chain, and Z represents a straight-chain or branched, optionally hydroxyl-substituted aliphatic radical having 1-8 carbon atoms of which 1-4 carbon atoms are located in the chain, m denotes the numbers 0 or 1 and n denotes the numbers 2 or 3, and acid addition salts thereof are described. These compounds are prepared by a suitable 2-substitution of compounds of the formula <IMAGE> [GB1489086A]
IE2531/74A 1973-12-21 1974-12-09 Dithiolanes and dithianes IE40788B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IE2292/77A IE40790B1 (en) 1973-12-21 1974-12-09 Aminoketones
IE229174A IE40789B1 (en) 1973-12-21 1974-12-09 Dithianes and dithiolanes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1803073A CH611614A5 (en) 1973-12-21 1973-12-21 Process for the preparation of heterocyclic compounds

Publications (2)

Publication Number Publication Date
IE40788L true IE40788L (en) 1975-06-21
IE40788B1 IE40788B1 (en) 1979-08-15

Family

ID=4429892

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2531/74A IE40788B1 (en) 1973-12-21 1974-12-09 Dithiolanes and dithianes

Country Status (24)

Country Link
JP (1) JPS595594B2 (en)
AT (5) AT344693B (en)
AU (1) AU511714B2 (en)
BE (1) BE823625A (en)
CA (4) CA1057295A (en)
CH (3) CH611614A5 (en)
DD (1) DD116829A5 (en)
DE (2) DE2463173C2 (en)
DK (1) DK148323C (en)
ES (5) ES433172A1 (en)
FI (1) FI67216C (en)
FR (1) FR2255064B1 (en)
GB (3) GB1489087A (en)
HK (1) HK43380A (en)
HU (1) HU170429B (en)
IE (1) IE40788B1 (en)
IL (3) IL46146A (en)
LU (1) LU71530A1 (en)
NL (1) NL158496B (en)
NO (1) NO142669C (en)
PH (3) PH19393A (en)
SE (2) SE415763B (en)
YU (1) YU39311B (en)
ZA (1) ZA747526B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2515173A1 (en) * 1981-10-28 1983-04-29 Delalande Sa 3-Methoxy 4-alkoxy benzaldehyde(s) - useful as intermediates for antibacterials, esp. trimethoprim and tetroxoprim
JPS60142297U (en) * 1984-02-29 1985-09-20 株式会社豊田自動織機製作所 Rotating device for swiveling driver's seat in forklift
JPS62171328U (en) * 1986-04-23 1987-10-30
DE3642331A1 (en) * 1986-12-11 1988-06-23 Basf Ag BASICLY SUBSTITUTED PHENYL ACETONITRILES, THEIR PRODUCTION AND THE MEDICINAL PRODUCTS CONTAINING THEM
US5434179A (en) * 1989-06-06 1995-07-18 Takeda Chemical Industries, Ltd. Method for improving brain function using cholinesterase-inhibiting aminoketone compounds
MXPA04006344A (en) 2001-12-28 2005-03-31 Takeda Pharmaceutical Preventives/remedies for urinary disturbance.
US20100137403A1 (en) * 2008-07-10 2010-06-03 Scott Malstrom Method for enhancing cognition or inhibiting cognitive decline

Also Published As

Publication number Publication date
IE40788B1 (en) 1979-08-15
DE2463173C2 (en) 1987-01-29
ATA38978A (en) 1978-10-15
PH13396A (en) 1980-03-28
AT349014B (en) 1979-03-12
DE2460593B2 (en) 1979-01-18
IL52843A0 (en) 1977-10-31
YU39311B (en) 1984-10-31
AU7600874A (en) 1976-06-03
NL7416507A (en) 1975-06-24
ATA1022674A (en) 1977-12-15
AU3224278A (en) 1978-05-25
NO744615L (en) 1975-07-21
HU170429B (en) 1977-06-28
IL46146A (en) 1980-09-16
FR2255064A1 (en) 1975-07-18
NO142669B (en) 1980-06-16
AT349012B (en) 1979-03-12
AT350053B (en) 1979-05-10
CH611614A5 (en) 1979-06-15
JPS595594B2 (en) 1984-02-06
IL46146A0 (en) 1975-03-13
CA1086320A (en) 1980-09-23
JPS5095267A (en) 1975-07-29
ATA39178A (en) 1978-08-15
NL158496B (en) 1978-11-15
ATA38878A (en) 1978-08-15
CA1072966A (en) 1980-03-04
FI67216C (en) 1985-02-11
IL52844A0 (en) 1977-10-31
ATA38778A (en) 1978-08-15
CH620920A5 (en) 1980-12-31
BE823625A (en) 1975-06-20
AT344693B (en) 1978-08-10
YU336874A (en) 1982-05-31
DK148323C (en) 1986-03-03
ZA747526B (en) 1975-12-31
NO142669C (en) 1980-09-24
ES451137A1 (en) 1977-08-16
DK668174A (en) 1975-08-25
SE434746B (en) 1984-08-13
FR2255064B1 (en) 1978-03-24
FI67216B (en) 1984-10-31
DK148323B (en) 1985-06-10
SE7416086L (en) 1975-06-23
CA1057295A (en) 1979-06-26
FI352774A (en) 1975-06-22
GB1489087A (en) 1977-10-19
LU71530A1 (en) 1976-11-11
DD116829A5 (en) 1975-12-12
DE2460593C3 (en) 1979-09-13
ES451135A1 (en) 1977-08-16
GB1489088A (en) 1977-10-19
ES433172A1 (en) 1977-04-16
CA1079290A (en) 1980-06-10
CH620921A5 (en) 1980-12-31
PH19393A (en) 1986-04-07
ES451134A1 (en) 1977-08-16
ES451136A1 (en) 1977-10-01
HK43380A (en) 1980-08-22
PH13326A (en) 1980-03-13
GB1489086A (en) 1977-10-19
AU511714B2 (en) 1980-09-04
AT349013B (en) 1979-03-12
SE415763B (en) 1980-10-27
DE2460593A1 (en) 1975-07-03

Similar Documents

Publication Publication Date Title
ES422581A1 (en) Thieno{8 3,2-c{9 pyridine derivatives
EP0048763A4 (en) Sulfur-containing acylamino acids.
ES463803A1 (en) O-[3-(4-Substituted-piperazin-1-yl)-2-hydroxypropyl]-hydroxylamines
IE41440L (en) Thiatetracyclines
IE40788B1 (en) Dithiolanes and dithianes
IE44069L (en) Noroxymorphones
DE3267188D1 (en) Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same
IE43651L (en) Benzisoquinolin-piperidine derivatives
IE42672L (en) Thieno-tetrahydropyridine derivatives
IE43717L (en) Alkylsulphonylamino phenyl cephalosporins.
IE43483L (en) Thiopyrano-pyrazoles
ES423699A1 (en) 3-oxyiminomethyl-cephalosporins
IE42711L (en) THIENO (3,2-c) PYRIDINE DERIVATIVES
DE2963164D1 (en) Alpha-aminophenylacetic acid derivatives for use in the treatment of inflammations and novel alpha-aminophenylacetic acid derivatives
IE42962L (en) Phthalimidine and benzisothiazoline derivatives.
DK52383D0 (en) PROCEDURE FOR THE PREPARATION OF CARBACYCLINE DERIVATIVES
ES469450A1 (en) Benzylpyrimidine derivatives
JPS52100473A (en) Novel azimidebenzamide derivative and its production
IE40722L (en) Indolopiperidino -alkylphenothiazines
JPS5269491A (en) Preparation of high polymeric selenium compounds
IE44951L (en) Pyridoindoles
JPS51145548A (en) Stabilizers for polymeric materials
JPS5283710A (en) Sulfur-containing amino acid derivatives
IE37963B1 (en) A disinfectant composition incorporating mono-oxycarboxylate salts of bis-biguanidines
ZA76563B (en) New salts of the monphosphoric acid ester of 2,2&#39;-dihydroxy - 3,3&#39;,5,5&#39; - tetrabromobiphenyl